Pasithea Therapeutics Corp.
KTTA
$0.58
$0.00-0.60%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.87M | -10.11M | -3.04M | -3.72M | -3.56M |
| Total Depreciation and Amortization | 157.50K | 157.50K | 181.60K | 161.70K | 162.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.40M | 4.67M | 109.00K | 65.80K | 28.90K |
| Change in Net Operating Assets | -672.30K | -111.30K | -143.20K | -380.30K | 316.30K |
| Cash from Operations | -4.79M | -5.40M | -2.89M | -3.87M | -3.06M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | 11.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 11.00K | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -179.30K |
| Issuance of Common Stock | 800.00 | 56.46M | 0.00 | 5.85M | 1.65M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -39.30K | -116.10K | -113.50K | -- |
| Cash from Financing | 800.00 | 56.42M | -116.10K | 5.74M | 1.47M |
| Foreign Exchange rate Adjustments | 28.10K | 500.00 | 12.70K | 5.60K | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.76M | 51.04M | -2.99M | 1.88M | -1.58M |